| Targeting nitric oxide: say NO to metastasis TP Reddy, SA Glynn, TR Billiar, DA Wink, JC Chang Clinical Cancer Research 29 (10), 1855-1868, 2023 | 16 | 2023 |
| Leukosome-based siRNA strategy for targeting ribosomal protein L39 (RPL39) in metaplastic breast cancer MF Chervo, C Mancino, F Giordano, TP Reddy, W Qian, J Zhou, ... Cancer Research 83 (7_Supplement), 2709-2709, 2023 | | 2023 |
| NOS inhibition reverses epithelial-to-mesenchymal transition and synergizes with alpelisib in metaplastic breast cancer TP Reddy, A Puri, L Guzman-Rojas, C Thomas, W Qian, J Zhou, H Zhao, ... Cancer Research 83 (7_Supplement), 3447-3447, 2023 | | 2023 |
| Abstract P4-08-05: NOS inhibition reverses epithelial-to-mesenchymal transition and synergizes with alpelisib in metaplastic breast cancer T Reddy, A Puri, L Guzman, W Qian, J Zhou, R Rosato, H Zhao, ... Cancer Research 83 (5_Supplement), P4-08-05-P4-08-05, 2023 | | 2023 |
| NOS inhibition augments PI3K inhibitor-induced DNA damage and mesenchymal-to-epithelial transition in metaplastic breast cancer TP Reddy, A Puri, L Guzman-Rojas, B Mahboubi, W Qian, J Zhou, B Kim, ... Cancer Research 82 (12_Supplement), 2658-2658, 2022 | | 2022 |
| Inducible nitric oxide synthase activates PI3K/Akt signaling via PTEN S-nitrosylation in triple-negative breast cancer TP Reddy, L Guzman-Rojas, RR Rosato, W Qian, H Zhao, JC Chang CANCER RESEARCH 82 (4), 2022 | | 2022 |
| Abstract P5-17-04: Combined PI3K and NOS inhibition enhances efficacy of taxane-based chemotherapy in metaplastic breast cancer TP Reddy, B Mahboubi, RR Rosato, L Guzman-Rojas, W Qian, J Zhou, ... Cancer Research 82 (4_Supplement), P5-17-04-P5-17-04, 2022 | | 2022 |
| Abstract PD3-01: Inducible nitric oxide synthase activates PI3K/Akt signaling via PTEN S-nitrosylation in triple-negative breast cancer TP Reddy, L Guzman-Rojas, RR Rosato, W Qian, H Zhao, JC Chang Cancer Research 82 (4_Supplement), PD3-01-PD3-01, 2022 | | 2022 |
| Utility of Cell-Free DNA Detection in Transplant Oncology T Reddy, A Esmail, JC Chang, RM Ghobrial, M Abdelrahim Cancers 14 (3), 743, 2022 | 16 | 2022 |
| Abstract PS11-17: Combination PI3K and NOS targeted therapy for metaplastic breast cancer TP Reddy, RR Rosato, L Guzman, W Qian, J Zhou, H Wang, ... Cancer Research 81 (4_Supplement), PS11-17-PS11-17, 2021 | | 2021 |
| A comprehensive overview of metaplastic breast cancer: clinical features and molecular aberrations TP Reddy, RR Rosato, X Li, S Moulder, H Piwnica-Worms, JC Chang Breast Cancer Research 22, 1-11, 2020 | 128 | 2020 |
| Simultaneous targeting of HER family pro-survival signaling with Pan-HER antibody mixture is highly effective in TNBC: a preclinical trial with PDXs TP Reddy, DS Choi, AC Anselme, W Qian, W Chen, J Lantto, ID Horak, ... Breast Cancer Research 22, 1-12, 2020 | 14 | 2020 |
| Chemotherapy rechallenge in metastatic colon cancer: A case report and literature review TP Reddy, U Khan, EA Burns, M Abdelrahim World Journal of Clinical Oncology 11 (11), 959, 2020 | 7 | 2020 |
| Combination PI3K and NOS targeted therapy for metaplastic breast cancer T Reddy, R Rosato, L Guzman, W Qian, J Zhou, H Piwnica-Worms, ... 32nd EORTC-NCI-AACR Symposium - Poster Session 138 (2), S49, 2020 | | 2020 |
| Procedure-Economical, Enantioselective Total Syntheses of Polycyclic Natural Products and Analogues Containing a 3a-Hydroxyhexahydropyrrolo [2, 3-b] indole-2-carboxylic Acid … PQ Huang Synlett 31 (17), 1681-1690, 2020 | 5 | 2020 |
| Metastatic triple‐negative breast cancer: Established and emerging treatments A Puri, TP Reddy, TA Patel, JC Chang The Breast Journal 26 (9), 1793-1796, 2020 | 6 | 2020 |
| Abstract P3-03-05: Elucidating the synergistic relationship between the iNOS and PI3K/Akt pathways for treatment of metaplastic breast cancer TP Reddy, R Rosato, L Guzman, W Qian, J Zhou, AJ Kozielski, JC Chang Cancer Research 80 (4_Supplement), P3-03-05-P3-03-05, 2020 | | 2020 |
| Chromosomal alterations of pediatric malignancy in a West Texas population A Rajan, S Tonk, C Bose, S Singh, S Swarup, T Reddy, S Chavali, ... The Southwest Respiratory and Critical Care Chronicles 8 (33), 7-28, 2020 | 1 | 2020 |
| Abstract B79: CXCR4 inhibition facilitates anti-PD-1 immunotherapy by reprogramming the tumor microenvironment during sorafenib treatment in hepatocellular carcinoma Y Chen, T Reiberger, R Ramjiawan, MR Ng, T Hato, EC Unan, TP Reddy, ... Cancer Immunology Research 3 (10_Supplement), B79-B79, 2015 | | 2015 |
| CXCR4 inhibition facilitates anti-PD-1 immunotherapy by reprogramming the tumor microenvironment during sorafenib treatment in hepatocellular carcinoma Y Chen, T Reiberger, R Ramjiawan, MR Ng, T Hato, EC Unan, TP Reddy, ... Cancer Immunology Research 3 (10), 2015 | 1 | 2015 |
P. Hemachandra ReddyTexas Tech Health Sciences Center在 ttuhsc.edu 的电子邮件经过验证
